Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...